Bit Capital Gmb H G1 Therapeutics, Inc. Transaction History

Bit Capital Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Feb 12, 2025	SELL	$2.57 - $8.16 $354,007 - $1.12 Million	-137,746 Closed	0 $0
Q4 2022 Feb 12, 2025	BUY	$5.19 - $13.5 $594,498 - $1.55 Million	114,547 Added 493.76%	137,746 $748 Million
Q3 2022 Feb 12, 2025	BUY	$5.17 - $16.99 $94,088 - $309,201	18,199 Added 363.98%	23,199 $290 Million
Q1 2022 Feb 12, 2025	BUY	$7.6 - $11.02 $38,000 - $55,100	5,000 New	5,000 $38 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.